A Phase 1/2 Study of Durvalumab and Monalizumab in Adult Subjects with Select Advanced Solid Tumors

Project: Research

Project Details

Project Description

NMA HREC Reference Number: MDF/53908/DEF-2019-172472(v1)
(ERM Project ID: 53908)
NMA SSA Reference Number: SSA/53908/MonH-2019-176189(v1)
Monash Health Ref: RES-19-0000-414X

Effective start/end date1/07/1930/06/24


  • Clinical trial
  • treatment efficacy
  • solid tumours